Abstract
Modern retinal imaging creates gigantic amounts of data (big data) of anatomic information. At the same time patient numbers and interventions are increasing exponentially. Introduction of artificial intelligence (AI) for optimization of personalized therapy and diagnosis. Deep learning was introduced for automated segmentation and recognition of risk factors and activity levels in retinal diseases. Automated algorithms enable the precise identification and quantification of retinal fluid in all compartments.Earlydetection of retinopathy in diabetes or glaucoma or risk determination for the development of age-related macular degeneration (AMD) are possible as well as an individual visual prognosis and evaluation of the need for retreatment in intravitreal injection therapy. Methods using AIconstitute abreakthrough perspective for the introduction of individualized medicine and optimization of diagnosis and therapy, screening and prognosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
